Biofrontera (NASDAQ:BFRI) reported results for the first quarter of 2023.
- Biofrontera posted a loss per share of 28 cents. That was much wider than the analyst estimate for a loss of 19 cents.
- The company reported revenue of $8.73 million.
- That was also lower than the analyst estimate for revenue of $9.15 million.
- You can read the full Biofrontera press release here.
On the date of publication, Sarah Smith did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Sarah Smith is the Editor-in-Chief of InvestorPlace.com.